US 10759793
2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors
granted A61PA61P1/04A61P11/00
Quick answer
US patent 10759793 (2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors) held by Almirall, S.A. expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P11/02, A61P11/06